Computed body tomography with a new nonionic contrast agent: Comparison of ioversol with sodium/meglumine diatrizoate

Bruce L. McClennan, Jay Heiken, Joseph K.T. Lee, Martin A. James

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The authors undertook a double-blind parallel group comparative study of 80 adult patients to examine the efficacy, safety, and tolerance of ioversol and sodium/meglumine diatrizoate in patients undergoing computed body tomography (CT). All procedures were considered diagnostic, although the scan quality of four procedures enhanced with sodium/meglumine diatrizoate was rated fair. Both contrast media induced clinically insignificant postprocedure decreases in mean systolic and diastolic blood pressure. There were no statistically significant differences between the two contrast media in their effects on these or other vital signs. Ioversol was better tolerated, as evidenced by significantly lower pain and heat scores. There was a remarkable difference in adverse side effects induced by ioversol (n = 0) and sodium/meglumine diatrizoate (n = 14 [35%], including six of moderate severity). Ioversol is a safe and effective nonionic contrast agent for contrast-enhanced body CT.

Original languageEnglish (US)
Pages (from-to)S35-S38
JournalInvestigative Radiology
Volume24
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

ioversol
Diatrizoate Meglumine
Diatrizoate
Contrast Media
Tomography
Blood Pressure
Vital Signs
Hot Temperature
Safety
Pain

Keywords

  • Computed tomography
  • Diatrizoate
  • Ioversol
  • Nonionic contrast media

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Computed body tomography with a new nonionic contrast agent : Comparison of ioversol with sodium/meglumine diatrizoate. / McClennan, Bruce L.; Heiken, Jay; Lee, Joseph K.T.; James, Martin A.

In: Investigative Radiology, Vol. 24, 01.01.1989, p. S35-S38.

Research output: Contribution to journalArticle

@article{cf162f2e21fc4eff94ca52404b129e64,
title = "Computed body tomography with a new nonionic contrast agent: Comparison of ioversol with sodium/meglumine diatrizoate",
abstract = "The authors undertook a double-blind parallel group comparative study of 80 adult patients to examine the efficacy, safety, and tolerance of ioversol and sodium/meglumine diatrizoate in patients undergoing computed body tomography (CT). All procedures were considered diagnostic, although the scan quality of four procedures enhanced with sodium/meglumine diatrizoate was rated fair. Both contrast media induced clinically insignificant postprocedure decreases in mean systolic and diastolic blood pressure. There were no statistically significant differences between the two contrast media in their effects on these or other vital signs. Ioversol was better tolerated, as evidenced by significantly lower pain and heat scores. There was a remarkable difference in adverse side effects induced by ioversol (n = 0) and sodium/meglumine diatrizoate (n = 14 [35{\%}], including six of moderate severity). Ioversol is a safe and effective nonionic contrast agent for contrast-enhanced body CT.",
keywords = "Computed tomography, Diatrizoate, Ioversol, Nonionic contrast media",
author = "McClennan, {Bruce L.} and Jay Heiken and Lee, {Joseph K.T.} and James, {Martin A.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1097/00004424-198906001-00009",
language = "English (US)",
volume = "24",
pages = "S35--S38",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Computed body tomography with a new nonionic contrast agent

T2 - Comparison of ioversol with sodium/meglumine diatrizoate

AU - McClennan, Bruce L.

AU - Heiken, Jay

AU - Lee, Joseph K.T.

AU - James, Martin A.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - The authors undertook a double-blind parallel group comparative study of 80 adult patients to examine the efficacy, safety, and tolerance of ioversol and sodium/meglumine diatrizoate in patients undergoing computed body tomography (CT). All procedures were considered diagnostic, although the scan quality of four procedures enhanced with sodium/meglumine diatrizoate was rated fair. Both contrast media induced clinically insignificant postprocedure decreases in mean systolic and diastolic blood pressure. There were no statistically significant differences between the two contrast media in their effects on these or other vital signs. Ioversol was better tolerated, as evidenced by significantly lower pain and heat scores. There was a remarkable difference in adverse side effects induced by ioversol (n = 0) and sodium/meglumine diatrizoate (n = 14 [35%], including six of moderate severity). Ioversol is a safe and effective nonionic contrast agent for contrast-enhanced body CT.

AB - The authors undertook a double-blind parallel group comparative study of 80 adult patients to examine the efficacy, safety, and tolerance of ioversol and sodium/meglumine diatrizoate in patients undergoing computed body tomography (CT). All procedures were considered diagnostic, although the scan quality of four procedures enhanced with sodium/meglumine diatrizoate was rated fair. Both contrast media induced clinically insignificant postprocedure decreases in mean systolic and diastolic blood pressure. There were no statistically significant differences between the two contrast media in their effects on these or other vital signs. Ioversol was better tolerated, as evidenced by significantly lower pain and heat scores. There was a remarkable difference in adverse side effects induced by ioversol (n = 0) and sodium/meglumine diatrizoate (n = 14 [35%], including six of moderate severity). Ioversol is a safe and effective nonionic contrast agent for contrast-enhanced body CT.

KW - Computed tomography

KW - Diatrizoate

KW - Ioversol

KW - Nonionic contrast media

UR - http://www.scopus.com/inward/record.url?scp=0024349082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024349082&partnerID=8YFLogxK

U2 - 10.1097/00004424-198906001-00009

DO - 10.1097/00004424-198906001-00009

M3 - Article

C2 - 2687193

AN - SCOPUS:0024349082

VL - 24

SP - S35-S38

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

ER -